News about Global Pharma

Brainomix Appoints Khush F. Mehta as Chair to Support Global Expansion and Commercial Growth

Brainomix Appoints Khush F. Mehta as Chair to Support Global Expansion and Commercial Growth

Brainomix announced the appointment of Khush F. Mehta as Chair of the Board. He succeeds Professor Jacqueline ('Jackie') Hunter CBE, who has served as Chair for the past five years.

Global Pharma | 21/05/2025 | By Manvi 139

Torrent Pharmaceuticals Appoints Aman Mehta as Managing Director

Torrent Pharmaceuticals Appoints Aman Mehta as Managing Director

Torrent Pharmaceuticals has appointed Aman Mehta as Managing Director. His experience includes successful integration of acquisitions and strategic roles across Torrent Group's diverse sectors.

Global Pharma | 21/05/2025 | By Manvi 981

Hyalex Orthopaedics Receives FDA Approval to Advance Freestyle Knee Implant to Pivotal Trial

Hyalex Orthopaedics Receives FDA Approval to Advance Freestyle Knee Implant to Pivotal Trial

This approval paves the way for Hyalex to expand its Early Feasibility Study (EFS) into a pivotal clinical trial of its novel knee implant technology, supporting the company's continued efforts to bring this next-generation orthopedic solution to patients in need.

Global Pharma | 20/05/2025 | By Manvi 316

Steven Johnson Joins Zealand Pharma as Chief Development Officer

Steven Johnson Joins Zealand Pharma as Chief Development Officer

Zealand Pharma has appointed Steven Johnson as Chief Development Officer to lead regulatory and development strategies, bolstering its leadership team as it advances innovation in obesity and metabolic disease management.

Global Pharma | 20/05/2025 | By Manvi 449

Lupin and Honeywell Advance Collaboration to Introduce HFO Technology in Inhalers

Lupin and Honeywell Advance Collaboration to Introduce HFO Technology in Inhalers

Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants.

Global Pharma | 20/05/2025 | By Manvi 297

BLA for Novavax's COVID-19 Vaccine Secures USFDA Approval

BLA for Novavax's COVID-19 Vaccine Secures USFDA Approval

Novavax has received US FDA approval for the Biologics License Application (BLA) for its COVID-19 vaccine Nuvaxovid, targeting high-risk individuals aged 12 and above, triggering a USD 175 million milestone payment from Sanofi under their licensing agreement.

Global Pharma | 19/05/2025 | By Manvi 407

Olympus Appoints Slawek Kierner as CDO - Smart Connected Care

Olympus Appoints Slawek Kierner as CDO - Smart Connected Care

Olympus Corporation (Olympus) announced the appointment of Slawek Kierner to the role of Chief Digital Officer - Smart Connected Care (CDO-SCC), effective immediately.

Global Pharma | 19/05/2025 | By Manvi 201

Trax Surgical Receives FDA Clearance for LINKT Compression Staple System

Trax Surgical Receives FDA Clearance for LINKT Compression Staple System

Massachusetts based Trax Surgical, LLC, an orthopedic product development and distribution company principally serving the needs of the orthopedic extremities market, announced that they received FDA 510(k) clearance to market the LINKT™ Compression Staple System.

Global Pharma | 19/05/2025 | By Manvi 165

India's Pharma Sector Records 7.8 Percent Growth in April 2025, Catering to 20 Percent of Global Need

India's Pharma Sector Records 7.8 Percent Growth in April 2025, Catering to 20 Percent of Global Need

India’s pharmaceutical industry recorded 7.8 percent year-on-year growth in April 2025, driven by global demand, new product launches, and robust government initiatives positioning the country as a global hub for affordable, high-quality healthcare.

Global Pharma | 19/05/2025 | By Manvi 874

Fzata Announces Joining of Gianna Arnold on Board of Directors

Fzata Announces Joining of Gianna Arnold on Board of Directors

The pharmaceutical company, Fzata, Inc., informed about the appointment of Gianna Arnold on the Board of Directors. The company developed a next-generation oral biologics modality called Bioengineered Probiotic Yeast Medicines (BioPYM).

Global Pharma | 19/05/2025 | By Manvi 290

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members